315 related articles for article (PubMed ID: 28962904)
41. PepFect14 peptide vector for efficient gene delivery in cell cultures.
Veiman KL; Mäger I; Ezzat K; Margus H; Lehto T; Langel K; Kurrikoff K; Arukuusk P; Suhorutšenko J; Padari K; Pooga M; Lehto T; Langel Ü
Mol Pharm; 2013 Jan; 10(1):199-210. PubMed ID: 23186360
[TBL] [Abstract][Full Text] [Related]
42. Uptake Mechanism and Direct Translocation of a New CPP for siRNA Delivery.
Pan R; Xu W; Ding Y; Lu S; Chen P
Mol Pharm; 2016 Apr; 13(4):1366-74. PubMed ID: 26937821
[TBL] [Abstract][Full Text] [Related]
43. A novel amphipathic cell-penetrating peptide based on the N-terminal glycosaminoglycan binding region of human apolipoprotein E.
Ohgita T; Takechi-Haraya Y; Nadai R; Kotani M; Tamura Y; Nishikiori K; Nishitsuji K; Uchimura K; Hasegawa K; Sakai-Kato K; Akaji K; Saito H
Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):541-549. PubMed ID: 30562499
[TBL] [Abstract][Full Text] [Related]
44. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
[TBL] [Abstract][Full Text] [Related]
45. Lipoprotein complex of equine lysozyme with oleic acid (ELOA) interactions with the plasma membrane of live cells.
Vukojević V; Bowen AM; Wilhelm K; Ming Y; Ce Z; Schleucher J; Hore PJ; Terenius L; Morozova-Roche LA
Langmuir; 2010 Sep; 26(18):14782-7. PubMed ID: 20735022
[TBL] [Abstract][Full Text] [Related]
46. Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
Kim S; Hyun S; Lee Y; Lee Y; Yu J
Biomacromolecules; 2016 Sep; 17(9):3007-15. PubMed ID: 27442521
[TBL] [Abstract][Full Text] [Related]
47. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
[TBL] [Abstract][Full Text] [Related]
48. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Divita G
Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
[TBL] [Abstract][Full Text] [Related]
49. Transduction of peptides and proteins into live cells by cell penetrating peptides.
Mussbach F; Franke M; Zoch A; Schaefer B; Reissmann S
J Cell Biochem; 2011 Dec; 112(12):3824-33. PubMed ID: 21826709
[TBL] [Abstract][Full Text] [Related]
50. Targeted gene silencing in human embryonic stem cells using cell-penetrating peptide PepFect 14.
Ervin EH; Pook M; Teino I; Kasuk V; Trei A; Pooga M; Maimets T
Stem Cell Res Ther; 2019 Jan; 10(1):43. PubMed ID: 30678718
[TBL] [Abstract][Full Text] [Related]
51. Membrane Molecular Interactions and Induced Structures of CPPs.
Madani F; Gräslund A
Methods Mol Biol; 2022; 2383():153-165. PubMed ID: 34766288
[TBL] [Abstract][Full Text] [Related]
52. Charge Distribution Fine-Tunes the Translocation of α-Helical Amphipathic Peptides across Membranes.
Ablan FDO; Spaller BL; Abdo KI; Almeida PF
Biophys J; 2016 Oct; 111(8):1738-1749. PubMed ID: 27760360
[TBL] [Abstract][Full Text] [Related]
53. Cell-Penetrating Peptides Delivering siRNAs: An Overview.
Falato L; Gestin M; Langel Ü
Methods Mol Biol; 2021; 2282():329-352. PubMed ID: 33928583
[TBL] [Abstract][Full Text] [Related]
54. Vesicles mimicking normal and cancer cell membranes exhibit differential responses to the cell-penetrating peptide Pep-1.
Almarwani B; Phambu EN; Alexander C; Nguyen HAT; Phambu N; Sunda-Meya A
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1394-1402. PubMed ID: 29621495
[TBL] [Abstract][Full Text] [Related]
55. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics.
Lönn P; Kacsinta AD; Cui XS; Hamil AS; Kaulich M; Gogoi K; Dowdy SF
Sci Rep; 2016 Sep; 6():32301. PubMed ID: 27604151
[TBL] [Abstract][Full Text] [Related]
56. Translocation of cell-penetrating peptides across the plasma membrane is controlled by cholesterol and microenvironment created by membranous proteins.
Pae J; Säälik P; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
J Control Release; 2014 Oct; 192():103-13. PubMed ID: 25016968
[TBL] [Abstract][Full Text] [Related]
57. Cellular uptake of Aib-containing amphipathic helix peptide.
Wada S; Tsuda H; Okada T; Urata H
Bioorg Med Chem Lett; 2011 Oct; 21(19):5688-91. PubMed ID: 21875799
[TBL] [Abstract][Full Text] [Related]
58. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
[TBL] [Abstract][Full Text] [Related]
59. Cell Penetrating Peptides: A Promising Tool for the Cellular Uptake of Macromolecular Drugs.
Zhu P; Jin L
Curr Protein Pept Sci; 2018; 19(2):211-220. PubMed ID: 28699510
[TBL] [Abstract][Full Text] [Related]
60. Characterization of cell-penetrating lipopeptide micelles by spectroscopic methods.
Gehne S; Sydow K; Dathe M; Kumke MU
J Phys Chem B; 2013 Nov; 117(46):14215-25. PubMed ID: 24188016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
